Wang, Long-Hai
Marfil-Garza, Braulio A. http://orcid.org/0000-0002-7224-2127
Ernst, Alexander U. http://orcid.org/0000-0001-6209-8486
Pawlick, Rena L.
Pepper, Andrew R. http://orcid.org/0000-0002-2227-4446
Okada, Kento http://orcid.org/0000-0003-4658-6871
Epel, Boris
Viswakarma, Navin
Kotecha, Mrignayani
Flanders, James Arthur
Datta, Ashim K. http://orcid.org/0000-0002-1397-6892
Gao, Hong-Jie
You, Ye-Zi http://orcid.org/0000-0003-0319-4165
Ma, Minglin http://orcid.org/0000-0002-9553-7526
Shapiro, A. M. James http://orcid.org/0000-0002-6215-0990
Article History
Received: 16 May 2022
Accepted: 25 October 2023
First Online: 5 December 2023
Competing interests
: A.M.J.S. serves as a consultant to ViaCyte Inc., Vertex Inc., Hemostemix Inc. and Aspect Biosystems Ltd. B.E. discloses financial interests in O2M. A.M.J.S. holds patents (US10434122B2 and CA2865122A1) for the ‘device-less’ prevascularization technique described in this paper. J.A.F. and M.M. are inventors on a patent application (US10493107B2) that covers the cell-encapsulation device described in this paper and are co-founders of Persista Bio. The other authors declare no competing interests.